We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $69.9B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+22.19%
3 Year Est. Return
+69.97%
5 Year Est. Return
10 Year Est. Return
AUM
$57.4B
AUM Growth
+$1.24B
Cap. Flow
-$8.13B
Cap. Flow %
-14.17%
Top 10 Hldgs %
23.56%
Holding
2,416
New
140
Increased
1,068
Reduced
929
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 10.7%
3 Financials 10.19%
4 Industrials 7.27%
5 Consumer Discretionary 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
2201
DELISTED
Hanesbrands
HBI
$110K ﹤0.01%
22,261
-8
-0% -$39
BHK icon
2202
BlackRock Core Bond Trust
BHK
$642M
$109K ﹤0.01%
10,278
+18
+0.2% +$190
OUST icon
2203
Ouster
OUST
$2.29B
$108K ﹤0.01%
10,955
PRPL icon
2204
Purple Innovation
PRPL
$33.2M
$108K ﹤0.01%
4,140
PKST
2205
DELISTED
Peakstone Realty Trust
PKST
$107K ﹤0.01%
10,065
-357
-3% -$4.69K
NAUT icon
2206
Nautilus Biotechnolgy
NAUT
$215M
$106K ﹤0.01%
+45,350
New +$118K
RNRG icon
2207
Global X Renewable Energy Producers ETF
RNRG
$30.3M
$105K ﹤0.01%
3,531
ZUO
2208
DELISTED
Zuora, Inc.
ZUO
$104K ﹤0.01%
10,518
ASTL icon
2209
Algoma Steel
ASTL
$455M
$104K ﹤0.01%
15,000
LFMD icon
2210
LifeMD
LFMD
$179M
$103K ﹤0.01%
15,055
+55
+0.4% +$503
PLL
2211
DELISTED
Piedmont Lithium
PLL
$102K ﹤0.01%
10,217
GERN icon
2212
Geron
GERN
$911M
$100K ﹤0.01%
23,646
-29,922
-56% -$117K
KINS icon
2213
Kingstone Companies
KINS
$288M
$100K ﹤0.01%
20,000
GRNT icon
2214
Granite Ridge Resources
GRNT
$640M
$98.6K ﹤0.01%
15,572
VMEO
2215
DELISTED
Vimeo
VMEO
$97.7K ﹤0.01%
26,189
-423
-2% -$1.6K
FATE icon
2216
Fate Therapeutics
FATE
$281M
$97.3K ﹤0.01%
29,649
-7,854
-21% -$34.4K
ABEO icon
2217
Abeona Therapeutics
ABEO
$345M
$95K ﹤0.01%
22,404
+8,502
+61% +$43.4K
ERNA icon
2218
Eterna Therapeutics
ERNA
$4.58M
$91.2K ﹤0.01%
134
KYNB
2219
Kyntra Bio
KYNB
$28.5M
$91.1K ﹤0.01%
4,084
RDFN
2220
DELISTED
Redfin
RDFN
$90.9K ﹤0.01%
15,129
+533
+4% +$3.33K
DSGN icon
2221
Design Therapeutics
DSGN
$736M
$90.3K ﹤0.01%
26,965
BDSX icon
2222
Biodesix
BDSX
$228M
$90.2K ﹤0.01%
2,949
+2,174
+281% +$62.1K
ETW
2223
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
$90.2K ﹤0.01%
10,905
COCH icon
2224
Envoy Medical
COCH
$51M
$90.1K ﹤0.01%
+38,162
New +$142K
DDD icon
2225
3D Systems Corp
DDD
$420M
$90K ﹤0.01%
29,311
-59,617
-67% -$219K

Similar funds

Corient Private Wealth's Q2 2024 Portfolio in Review

As of Q2 2024, Corient Private Wealth held 2,416 positions worth $57.4B, up 2.2% from $56.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Corient Private Wealth withdrew a net $8.13B in Q2 2024, closing 100 positions and reducing 929 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $9.02M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Corient Private Wealth opened a new position in Nuveen Churchill Direct Lending worth $12.6M.

  • Corient Private Wealth's largest Q2 2024 buy was Nuveen Churchill Direct Lending: 721,458 shares worth $12.6M.
  • Corient Private Wealth added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $149M increase.
  • Corient Private Wealth's biggest Q2 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $8.26B.
  • Corient Private Wealth fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $9.02M.
  • Corient Private Wealth's ten largest holdings make up 24% of its $57.4B portfolio in Q2 2024.
  • Corient Private Wealth opened 140 new positions and closed 100 in Q2 2024.
  • Corient Private Wealth's portfolio value rose 2.2% quarter-over-quarter to $57.4B.

Based on Corient Private Wealth's 13F filing for Q2 2024, filed 13 Aug 2024.